About Lotus Labs Private Limited
Data last updated:
Lotus Labs Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India, a subsidiary of Actavis Dutch Holding B.V. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 26 November 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U73100MH1999PTC272443. Its GSTIN is 29AAACL5328D1ZO (Karnataka). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.05 Cr. It is led by directors including Gregg Robert Derosa and Sanjog Kailashchandra Sharma.
Its last annual general meeting (AGM) was held on 01 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Navi Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹54.98 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹11.86 Cr (net margin 21.6%) and EBITDA of ₹31.42 Cr (EBITDA margin 57.2%). Revenue has declined at a compounded annual rate (CAGR) of 23% over three years and 13% over five years.
The company has about 213 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹25.16 Cr on record. Court records list 10 cases involving the company, including 6 filed by the company and 4 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website lotuslabs.com.
Company details
CIN history
Lotus Labs has one previous CIN (Corporate Identification Number): U73100KA1999PTC025994. The current CIN is U73100MH1999PTC272443, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73100MH1999PTC272443 | Current |
| U73100KA1999PTC025994 | Previous |
Contact details
Lotus Labs Private Limited's registered office is in Navi Mumbai, Maharashtra. Its website is lotuslabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address10th Flr D Wing Tower II Seawoods Grand Central Plot No. R – 1 Sector – 40 Seawoods Railw, Ay Station, Navi Mumbai, Maharashtra, India – 400706
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Lotus Labs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Lotus Labs is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Lotus Labs Private Limited, buy the company report.
Financials of Lotus Labs Private Limited
FY 2025 filings availableLotus Labs Private Limited reported revenue of ₹54.98 Cr (up 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 9% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 13%. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹31.42 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.86 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 57.2% | ||||
| Net Profit Margin | 21.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lotus Labs Private Limited, buy the company report.
Board of directors of Lotus Labs Private Limited
Lotus Labs has 3 current directors and 25 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gregg Robert Derosa | Director | 07 Jan 2021 | 5 Years 9 Months | Current |
| Sanjog Kailashchandra Sharma | Director | 22 Mar 2021 | 5 Years 7 Months | Current |
| Anil Kumar Anand | Director | 08 Jun 2023 | 3 Years 4 Months | Current |
Peer comparison
Lotus Labs Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| MMSH Clinical Research Private Limited | ₹60.32 Cr (FY 2025) | 3.0% | Bangalore, Karnataka, India | |||
| Lotus Labs Private Limitedthis company | ₹54.98 Cr (FY 2025) | ₹11.86 Cr | 21.6% | 9.0% | 213 | Navi Mumbai, Maharashtra, India |
| Premier Research Group (India) Private Limited | ₹54.7 Cr (FY 2025) | 19.0% | Bengaluru, Karnataka, India | |||
| Norwich Clinical Services Private Limited | ₹51.26 Cr (FY 2025) | 18.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Lotus Labs Private Limited, buy the company report.
Auditor
Lotus Labs Private Limited is audited by MGB & Co LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MGB & Co LLP | FY 2023 | 101169W/W-100035 |
Shareholding
The shareholding of Lotus Labs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Lotus Labs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Oct 2007 | 10070983 | The Hongkong and Shanghai Banking Corporation Limited | ₹2.4 Cr | Satisfied | |
| 07 Aug 2007 | 10061268 | The Hongkong and Shanghai Banking Corporation Limited | ₹2.4 Cr | Satisfied | |
| 15 Jul 2007 | 10060073 | Dbs Bank Limited | ₹10 Cr | Satisfied | |
| 14 Oct 2003 | 90194498 | Canara Bank | ₹7.86 Cr | Satisfied | |
| 09 May 2000 | 90192258 | Canara Bank | ₹2.5 Cr | Satisfied |
To see the full charge records of Lotus Labs Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Lotus Labs Private Limited has 10 court cases on record: 6 filed by Lotus Labs, 4 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 8 | 3 | 0 |
| District courts | 2 | 1 | 0 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, GUJARAT | Court case (IAAP) | Filed against the company by Troikaa Pharmaceuticals Limited and 3 others | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Civil suit | Filed by the company against Transasia Bio-Medicals Ltd | Disposed |
| Bombay High Court | Court case (S) | Filed by the company against Transasia Bio-Medicals Ltd. | Disposed |
| High Court of Delhi | Commercial suit | Filed against the company by Incyte Holdings Corporation & Ors. | Disposed |
| High Court, KARNATAKA | Tax appeal | Filed against the company by Principal Commissioner of Central Tax | Disposed |
To see the full case history of Lotus Labs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Lotus Labs Private Limited has 14 MSME Form 1 returns on record between 2019 and 2024, listing 694 overdue payments to 69 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 69)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Symmetrix Computer Systems Private Limited | |||
| Eco Green Solution Systems Private Limited | |||
| an individual supplier | |||
| Bioorganics and Applied Materials Private Limited | |||
| Aic Enterprises Private Limited |
To see the full MSME payment records of Lotus Labs Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Lotus Labs Private Limited has a workforce of 213 employees on its EPFO records as of Apr 02, 2024, across 1 active EPFO establishment.
GST
Lotus Labs has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAACL5328D1ZO | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Lotus Labs Private Limited, buy the company report.
Recent activity
Lotus Labs Private Limited has 28 board changes on record since 2007: 3 appointments and 25 cessations. The latest: Anil Kumar Anand ceased to be Additional Director on 22 Aug 2023.
31 earlier events are in the company report.
Frequently asked questions
Lotus Labs is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 26 November 1999 (27+ years old) and is registered under CIN U73100MH1999PTC272443.
Lotus Labs has 3 current directors:
- Gregg Robert Derosa - Director
- Sanjog Kailashchandra Sharma - Director
- Anil Kumar Anand - Director
The latest financial statements of Lotus Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 01 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Lotus Labs is 29AAACL5328D1ZO, registered in Karnataka. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Lotus Labs is U73100MH1999PTC272443. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lotus Labs has 10 court cases on record: 6 filed by the company and 4 filed against it. Most are in the high courts.
Lotus Labs was incorporated on 26 November 1999, making it 27+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Lotus Labs by revenue are MMSH Clinical Research Private Limited, Premier Research Group (India) Private Limited, Norwich Clinical Services Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development).
Anil Kumar Anand ceased to be Additional Director on 22 Aug 2023. Anil Kumar Anand was appointed as Director on 08 Jun 2023. Gregg Robert Derosa ceased to be Additional Director on 19 Aug 2021. Lotus Labs has 28 board changes on record in total.
Lotus Labs has 14 MSME Form 1 returns on record between 2019 and 2024, listing 694 overdue payments to 69 micro and small suppliers. The latest return was filed on 25 Apr 2024.
Lotus Labs can be reached through the website lotuslabs.com. Its registered office is in Navi Mumbai, Maharashtra, India.
The registered office of Lotus Labs is at 10th Flr D Wing Tower II Seawoods Grand Central Plot No. R – 1 Sector – 40 Seawoods Railw, Ay Station, Navi Mumbai, Maharashtra, India – 400706.